Standard of Care: Protecting Your Heart and Managing Your Skin

Managing Erythrokeratodermia-cardiomyopathy (EKC) syndrome is a lifelong commitment that requires a partnership between you and a specialized medical team. Because there is no single “cure” for EKC, treatment focuses on two main goals: protecting the heart from weakening and keeping the skin as comfortable and flexible as possible ^[1][2].

Heart Protection: The “GDMT” Approach

When the heart’s pumping chamber shows signs of weakening, doctors use Guideline-Directed Medical Therapy (GDMT). This is a combination of medications proven to help the heart muscle work more efficiently and prevent it from changing shape (a process called “remodeling”) ^[3][4].

Commonly used medications include:

• Beta-Blockers: These slow the heart rate and lower blood pressure, giving the heart muscle more time to rest between beats ^[3].
• ACE Inhibitors or ARBs: These help relax blood vessels, making it easier for the heart to pump blood ^[3].
• ARNI (Angiotensin Receptor-Neprilysin Inhibitor): A newer class of medicine that combines two heart-protective actions and is often preferred for more significant heart failure ^[3].
• SGLT2 Inhibitors: Originally used for diabetes, these have been shown to significantly reduce the risk of heart-failure complications ^[3].

Medication choice and dosing differ substantially for children and adults and depend on ejection fraction, blood pressure, kidney function, and other factors. Standard heart-failure care may also involve mineralocorticoid-receptor antagonists or diuretics when indicated. State that these are examples of therapies a cardiologist may consider, not a prescription or preventive regimen for everyone.

Preventing Sudden Arrhythmia: The ICD Decision

One of the most complex parts of EKC care is deciding when to place an ICD (Implantable Cardioverter-Defibrillator). An ICD is a small device that monitors your heart rhythm and can deliver a life-saving shock if it detects a dangerous, rapid heartbeat ^[5][6].

In many conditions, doctors wait until the heart’s pumping strength (LVEF) drops below 35% to recommend an ICD. However, in DSP-related conditions like EKC, dangerous rhythms can happen even when the heart’s pumping strength is still normal ^[7][8].

Your doctor may use a DSP-specific risk score to help make this decision. This score looks at factors like ^[9]:

• Prior NSVT: Short bursts of fast heartbeats found on a Holter monitor.
• PVC Burden: The number of extra heartbeats in a 24-hour period.
• Sex: The risk profiles can differ between males and females.
• RV Dysfunction: Whether the right side of the heart is also affected.
• LGE (Scarring): The amount of scar tissue seen on a cardiac MRI.

ICD decisions also weigh prior cardiac arrest, device complications, and patient preferences. It involves shared decision-making rather than an automatic treatment.

Managing the Skin: Comfort and Barrier Support

Skin care in EKC is primarily supportive, meaning the goal is to manage symptoms rather than fix the underlying genetic cause.

• Emollients: Frequent use of heavy, oil-based moisturizers is essential to trap moisture and keep the skin from cracking ^[10].
• Keratolytics: These are products containing ingredients like urea, lactic acid, or salicylic acid that help break down the thickened patches of skin ^[10]. Note: Apply only a clinician-recommended product and amount. Avoid treating extensive fissured skin without advice, recognize infection, and ask about age-specific precautions because ingredients like salicylic acid can irritate or be absorbed through large or damaged areas.
• Retinoids: In some cases, a dermatologist may prescribe oral or topical retinoids to help regulate how quickly skin cells grow ^[11]. These require specialist monitoring for adverse effects and carry significant pregnancy-related precautions.
• Biologics: There is very limited evidence for using “biologic” drugs (like those used for psoriasis) in EKC. While one case report showed benefit, it is not yet considered a standard treatment ^[12].

Advanced Therapies and Pitfalls

If heart failure continues to progress despite optimal medication, your team may discuss advanced options:

• Cardiac Resynchronization Therapy (CRT): A special type of pacemaker that is used in selected patients with electrical dyssynchrony and appropriate ventricular dysfunction to help the heart beat more effectively ^[13].
• Heart Transplant: For “end-stage” heart failure where medications and devices are no longer enough, a transplant may be an option evaluated by an advanced heart failure team ^[14].

Important Warning: Risk management in EKC continues even when you feel well and your skin is clear, because internal heart scarring and arrhythmia risk can still be present ^[7][8].

Finally, you should discuss exercise limits with your cardiologist. While being active is good, intense “endurance-level” exercise (like competitive marathon running) has been linked to a higher risk of heart-injury episodes in people with DSP mutations ^[15]. Recommendations should be individualized to your rhythm findings, ventricular function, and symptoms. If you experience new chest pain (a potential myocardial injury or “hot phase”), there is no patient-directed anti-inflammatory protocol; seek urgent emergency evaluation immediately so a clinical team can determine the appropriate acute care.